Buy or sell Cleerly stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Cleerly Stock
Heart Disease Diagnosis Solutions
About Cleerly Stock
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
Cleerly is headquartered in New York, NY, and was founded in 2017. Notable investors include Fidelity Management and Research, Novartis, and T. Rowe Price.
Investors
Breyer Capital
Oscar Health, Circle, Shield AI, Stash Financial, Prosper Marketplace, C3 IoT, Grammarly, Etsy, Cleerly, Mark43
Cigna Ventures
DigiTx Partners
Fidelity Management and Research
MasterClass, Wheels Up, Rent the Runway, Somatus, ACV, The Honest Company, Cleerly, Oportun, 10X Genomics, Heal
Fidelity Management and Research Company
goPuff, Nuro, Bolt, Caris Life Sciences, Relativity Space, Deliveroo, Farmers Business Network, Checkr, Freenome, Bowery Farming
General Catalyst Partners
Snap, Jet, Stripe, Anduril Industries, Devoted Health, Lacework, Relativity Space, Oscar Health, Hopin, Vroom
LRVHealth
New Leaf Venture Partners
Novartis
Sands Capital Ventures
AppDynamics, BigBasket, DoorDash, UiPath, Scopely, Snyk, DocuSign, Upgrade, StockX, Outreach
T. Rowe Price
One97, Flipkart, WeWork, Cruise, Airbnb, Rivian, Magic Leap, Nuro, Caris Life Sciences, Vroom
Vensana Capital
Funding History
| April 2020 | $11.5M |
|---|---|
| June 2021 | $28.1M |
| June 2021 | $16.8M |
| February 2022 | $230M |
Management
Chief Executive Officer
James Min
Chief Medical Officer
James Earls
Press
builtinnyc - Jul, 26 2022
vator - Jul, 1 2021
TechCrunch - Jun, 23 2021
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
